The data highlight the possibility of SGLT 1/2 inhibitors having protective effects beyond heart failure and diabetes.

This month: smelling skills predict stroke risk, insights from LGBTQ+ clinicians, BP screening in public spaces, and more.

A patient who, despite risk factors or comorbidities, can get on a treadmill faces low mortality risk. But the reverse is ...